Eval. of Sirolimus in Treatment of Bilateral Geographic Atrophy
Eval. of Sirolimus in Treatment of Bilateral Geographic Atrophy
批准号:
8938341
负责人:
EMILY Y CHEW
金额:
$13.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectAge related macular degenerationAreaBilateralCellsClinical ProtocolsDrusenEyeFundus photographyImageInflammationInjection of therapeutic agentMasksMeasuresOutcomeParticipantPatientsPharmaceutical PreparationsReadingRelative (related person)RetinaSafetySirolimusTestingVisionbasedigitalgeographic atrophymaculapreventprimary outcomesecondary outcome
中文摘要
这项研究将确定一种名为西罗莫司的药物是否可以安全用于地理萎缩性GA患者,以及它是否有助于保护患者的视力。GA是干性老年性黄斑变性(AMD)的一种晚期形式。老年性黄斑变性影响黄斑,黄斑是视网膜的中心部分,是保持敏锐、清晰视力所必需的。AMD有两种类型,湿性和干性。在干性黄斑变性中,黄斑细胞死亡。GA至少部分是由炎症引起的。西罗莫司有助于预防炎症,因此可能有助于治疗GA。
英文摘要
This study will determine if a drug called sirolimus is safe to give to people with geographic atrophy GA and if it can help preserve vision in patients. GA is an advanced form of dry age-related macular degeneration (AMD). AMD affects the macula, the central part of the retina needed for sharp, clear vision. There are two types of AMD, wet and dry. In dry AMD, cells in the macula die.GA may at least partly be caused by inflammation. Sirolimus helps prevent inflammation and therefore may help treat GA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ranibizumab for Advanced Ocular Disease of VHL Disease
-
批准号:6968628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of V
-
批准号:7141780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study
-
批准号:7968439
-
项目类别:
-
资助金额:$3.06万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
FIND (Familial Investigation of Nephropathy in Diabetes)
-
批准号:8737631
-
项目类别:
-
资助金额:$0.95万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:8938315
-
项目类别:
-
资助金额:$2.42万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Medical Retina Fellowship
-
批准号:9362461
-
项目类别:
-
资助金额:$19.42万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
MACTEL1
-
批准号:8339801
-
项目类别:
-
资助金额:$1.64万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:10019993
-
项目类别:
-
资助金额:$5.51万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study
-
批准号:10020007
-
项目类别:
-
资助金额:$5.51万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
AMD Ryan Initiative Study (ARIS)
-
批准号:10266915
-
项目类别:
-
资助金额:$2.92万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:10930505
-
项目类别:
-
资助金额:$3.85万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study
-
批准号:10930515
-
项目类别:
-
资助金额:$3.85万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab (16-EI-0159)
-
批准号:10930533
-
项目类别:
-
资助金额:$3.85万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
MACTEL1
-
批准号:8149210
-
项目类别:
-
资助金额:$1.56万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Anti-VEGF Pegylated Aptamer for Advanced Ocular Disease
-
批准号:7141775
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Evaluation of Age-Related Eye Disease Study (AREDS) Clin
-
批准号:7141777
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Anti-VEGF Pegylated Aptamer for Advanced Ocular Disease
-
批准号:6968625
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
ACCORD (Action to Control Cardiovascular Risk in Diabetes)
-
批准号:8556831
-
项目类别:
-
资助金额:$2.44万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Eval. of Sirolimus in Treatment of Bilateral Geographic Atrophy
-
批准号:8737659
-
项目类别:
-
资助金额:$14.18万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
Age-Related Eye Disease Follow-up Study (AREDS) Follow-up Study
-
批准号:8938339
-
项目类别:
-
资助金额:$2.42万
-
财政年份:--
-
负责人:EMILY Y CHEW
-
依托单位:
海外基金